Home > Insider Trading > Filing (0001127602-21-025146)

Filing Details

Accession Number:: 0001127602-21-025146
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-10 16:45:59
Reporting Period:: 2021-09-09

Accepted Time:: 2021-09-10 16:45:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
91440	Snap-On Inc	SNA	Cutlery, Handtools & General Hardware (3420)	390622040

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1486096	John Aldo Pagliari	Snap-On Incorporated 2801 80Th Street Kenosha WI 53143	Sr Vp - Finance & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-09-09	8,000	$60.00	68,968	No	4	M	Direct
Common Stock	Disposition	2021-09-09	1,398	$220.14	67,570	No	4	S	Direct
Common Stock	Disposition	2021-09-09	914	$221.03	66,656	No	4	S	Direct
Common Stock	Disposition	2021-09-09	2,100	$222.26	64,556	No	4	S	Direct
Common Stock	Disposition	2021-09-09	500	$222.71	64,056	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-09-09	8,000	$0.00	8,000	$60.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000		2022-02-08	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$79.04		2023-02-13	22,500	22,500	Direct
Common Stock	Stock Option (Right to Buy)	$109.43		2024-02-13	33,000	33,000	Direct
Common Stock	Stock Option (Right to Buy)	$144.69		2025-02-12	34,000	34,000	Direct
Common Stock	Stock Option (Right to Buy)	$138.03		2026-02-11	35,000	35,000	Direct
Common Stock	Stock Option (Right to Buy)	$168.70		2027-02-09	36,000	36,000	Direct
Common Stock	Stock Option (Right to Buy)	$161.18		2028-02-15	26,052	26,052	Direct
Common Stock	Stock Option (Right to Buy)	$155.92	2020-02-14	2029-02-14	23,500	23,500	Direct
Common Stock	Stock Option (Right to Buy)	$155.34	2021-02-13	2030-02-13	23,500	23,500	Direct
Common Stock	Stock Option (Right to Buy)	$189.89	2022-02-11	2031-02-11	14,986	14,986	Direct
Common Stock	Restricted Stock Units	$0.00	2024-02-11	2024-02-11	2,337	2,337	Direct
Common Stock	Performance Units	$0.00			2,992	2,992	Direct
Common Stock	Performance Units	$0.00			2,840	2,840	Direct
Common Stock	Performance Units	$0.00			4,673	4,673	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2023-02-13	22,500	22,500	Direct
2024-02-13	33,000	33,000	Direct
2025-02-12	34,000	34,000	Direct
2026-02-11	35,000	35,000	Direct
2027-02-09	36,000	36,000	Direct
2028-02-15	26,052	26,052	Direct
2029-02-14	23,500	23,500	Direct
2030-02-13	23,500	23,500	Direct
2031-02-11	14,986	14,986	Direct
2024-02-11	2,337	2,337	Direct
	2,992	2,992	Direct
	2,840	2,840	Direct
	4,673	4,673	Direct

Footnotes

The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan.
Includes 12.1757 shares acquired under a dividend reinvestment plan.
This transaction was executed in multiple trades at prices ranging from $219.52 to $220.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
This transaction was executed in multiple trades at prices ranging from $220.57 to $221.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
This transaction was executed in multiple trades at prices ranging from $221.60 to $222.59. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
This transaction was executed in multiple trades at prices ranging from $222.61 to $223.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
Option fully vested.
Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan.
Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.
1 for 1.
The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.
If the Company achieves certain goals over the 2019-2021 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
If the Company achieves certain goals over the 2020-2022 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
If the Company achieves certain goals over the 2021-2023 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.